Mr Brain Health
A cognitive-health organization and digital platform that promotes routine blood-based biomarker screening for Alzheimer’s risk, develops protocolized biomarker monitoring and intervention frameworks, conducts research using de-identified participant data, and provides public education and care-coordination tools. The initiative is led by Aspen Decker and positions a technology platform to integrate diagnostic testing, telehealth coordination, algorithmic risk scoring, and longitudinal monitoring.
Industries
N/A
Nr. of Employees
medium (51-250)
Products
Educational content and multimedia (blogs, videos)
Written and video educational series covering dementia topics, differences between dementia types, cognitive health guides, and practical advice for caregivers.
Educational content and multimedia (blogs, videos)
Written and video educational series covering dementia topics, differences between dementia types, cognitive health guides, and practical advice for caregivers.
Services
Screening service coordinating blood-based amyloid and tau testing for early detection and longitudinal monitoring, recommended beginning at age 40.
Integration of multi-test biomarker data and clinical/genetic inputs into an algorithmic risk score to guide testing and treatment decisions.
Platform services to schedule telehealth appointments, share lab results with providers, and coordinate follow-up care.
Automatic enrollment (with opt-out) into de-identified research using platform and clinical data to study biomarker patterns, genetic risk, and treatment outcomes.
Screening service coordinating blood-based amyloid and tau testing for early detection and longitudinal monitoring, recommended beginning at age 40.
Integration of multi-test biomarker data and clinical/genetic inputs into an algorithmic risk score to guide testing and treatment decisions.
Platform services to schedule telehealth appointments, share lab results with providers, and coordinate follow-up care.
Automatic enrollment (with opt-out) into de-identified research using platform and clinical data to study biomarker patterns, genetic risk, and treatment outcomes.
Expertise Areas
- Biomarker-based diagnostics and longitudinal monitoring
- Clinical research design and collaboration
- Digital health platform development and telehealth coordination
- Regulatory compliance and HIPAA privacy practices
Key Technologies
- Blood-based amyloid and tau biomarker assays
- Algorithmic risk-scoring engines for biomarker integration
- Telehealth and care-coordination platforms
- Cloud analytics and tracking/pixel-based telemetry
News & Updates
Article profiling the founder and the platform’s approach to changing the healthcare system and building prevention-first solutions.
Article describing claimed advances in early detection and intervention approaches for Alzheimer’s risk.
Article profiling the founder and the platform’s approach to changing the healthcare system and building prevention-first solutions.
Article describing claimed advances in early detection and intervention approaches for Alzheimer’s risk.